freeze-thaw comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-12-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
The choice of solvent is guided by peptide properties and the intended downstream use. Water alone can dissolve many hydrophilic peptides, while hydrophobic sequences may require a small amount of an organic solvent or a buffered solution. Some peptides carry net charges that affect solubility across pH values. The pH of the final solution can influence stability and aggregation. In research settings, the solvent is selected to match the assay or analytical method rather than for any therapeutic purpose.
During reconstitution, liquid is directed toward the wall of the vial rather than forcefully onto the powder. Gentle swirling or inversion mixes the contents without creating excessive foam or shear. Foaming can denature some peptides and can make volume measurement difficult. Complete dissolution is often confirmed by visual inspection against a light source. Particles, cloudiness, or undissolved material may indicate incomplete mixing, aggregation, or a solubility limitation that requires further investigation.
The concentration of a reconstituted peptide is calculated from the mass of peptide powder and the volume of solvent added. This calculation assumes the powder contains only peptide, but many preparations include counterions, water, or salts. Analytical methods such as ultraviolet absorbance or amino acid analysis can estimate actual peptide content. The relationship between nominal and actual concentration is an area where measurements matter. Open questions remain about how aggregation changes the effective concentration in solution.
Peptide reconstitution is the process of dissolving a lyophilized peptide in a liquid to form a solution for later use. Lyophilization removes water under vacuum, leaving a dry powder or porous cake. Reconstitution reintroduces solvent so the peptide molecules return to a dissolved state. The solvent may be purified water, a buffer, or a mixture containing an organic co-solvent. The choice depends on the peptide sequence, its charge, and its hydrophobicity.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized powder or porous cake | Appearance depends on peptide sequence and drying cycle. |
| Solubility class | Sequence-dependent | Hydrophilic peptides often dissolve in water; hydrophobic peptides may require organic co-solvent or buffer. |
| Typical storage temperature (lyophilized) | -20 °C or below | Desiccant, light protection, and limited warming cycles are recommended. |
| Typical storage temperature (reconstituted) | 2–8 °C short term; -20 °C or below long term | Stability varies with pH, buffer, concentration, and peptide sequence; repeated freeze-thaw should be avoided. |
| Common analytical method | RP-HPLC and LC-MS | Used to check purity, identity, and related impurities; not a substitute for sterility testing. |
During reconstitution, solvent penetrates the powder, breaks interparticle contacts, and solvates polar and nonpolar groups. Gentle mixing or swirling can speed dissolution, while vigorous shaking may introduce foaming and surface denaturation. Aggregation becomes more likely when the peptide concentration exceeds its solubility or when the pH is near the isoelectric point. The link between a specific reconstitution method and long-term stability is not fully predictable from sequence alone. How excipients, container surfaces, and residual moisture influence aggregation remains an open question.
Lyophilization removes water from a peptide solution under vacuum, leaving a porous cake or a loose powder. The dry form often improves stability during shipping and storage because water-mediated degradation slows. Reconstitution reverses the process by adding a solvent so peptide molecules hydrate and enter solution. Complete dissolution depends on peptide sequence, purity, salt form, and any excipients present. Some lyophilized powders dissolve quickly, while others form haze, gels, or persistent particles.
Cold storage slows most degradation but does not stop it. Reconstituted solutions are commonly divided into aliquots and held at -20 °C or -80 °C, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation or precipitation, so single-use aliquots are preferred. Some peptides tolerate refrigeration for short intervals, while others require freezing immediately. Light-sensitive residues may need amber or foil-wrapped containers. The optimal condition remains peptide-specific and should be supported by stability data.
Analytical checks can detect changes in a reconstituted stock over time. Reverse-phase high-performance liquid chromatography can show loss of main peak, new impurity peaks, or altered retention. Mass spectrometry confirms molecular identity and can reveal modifications. Visual inspection for particles, color change, or turbidity provides a simple first check. If a solution shows signs of degradation or contamination, it is typically discarded rather than re-purified in a routine laboratory.
Once a peptide is dissolved, its solution is generally less stable than the dry powder. Chemical pathways such as hydrolysis, oxidation, and deamidation can alter the molecule, while physical processes can form aggregates or cause adsorption to container walls. The rate depends on pH, buffer composition, temperature, concentration, and the specific sequence. Aqueous stocks are therefore kept cold and used within a defined period. Stability testing is usually performed for each peptide rather than assumed from a general rule.
Microbial contamination is a concern for aqueous peptide solutions, especially those without preservatives. Bacteriostatic water contains an antimicrobial preservative and is used in some laboratory settings, while sterile water lacks preservatives. Filtration through a sterile filter can reduce particulates and microbes, but some peptides adsorb to filter membranes. The effect of preservatives on peptide stability is peptide-dependent and not fully predictable. Documentation of lot number, solvent, date, and storage conditions supports traceability and reproducibility.
After reconstitution, peptide solutions are generally less stable than lyophilized powders, and hydrolysis, oxidation, deamidation, and aggregation can occur in solution. Stability depends on peptide sequence, concentration, pH, buffer composition, temperature, light exposure, and dissolved oxygen. Many research protocols store reconstituted solutions at 4 °C for short periods or at -20 °C or -80 °C for longer periods. Repeated freeze-thaw cycles can promote aggregation and loss of activity. The optimal storage condition is peptide-specific and often determined empirically rather than predicted from sequence alone.
== Research == Much of Limbird's research has explored the activity of G-protein coupled receptors. She has demonstrated how alpha-2 adrenergic receptors are involved in regulation of blood pressure, suppression of pain, sedation and the action of opioid drugs. She has developed techniques for selectively manipulating such receptors. Limbird is the author of Cell Surface Receptors: A Short Course in Theory and Methods (1985, 1996, 2004); co-editor with Joel Hardman of the 9th (1995) and 10th (2001) editions of Goodman and Gilman’s Pharmacological Basis of Therapeutics; editor of Alpha2-Adrenergic Receptors (1988) and co-editor with Stephen Lanier of α2-Adrenergic Receptors. Structure, Function and Therapeutic Implications (1996). Limbird has served on the editorial boards of the Journal of Biological Chemistry, the American Journal of Physiology, and Molecular Pharmacology.
=== Film adaptation === In February 2013, Valve president Gabe Newell and film director J. J. Abrams announced that they were to collaborate on a film adaptation of the Portal series. In 2016, Abrams stated that he still has plans to direct these films in the future, with both films in the writing stage. Abrams confirmed in May 2021 that the film adaptation was still in the works as they were still working on a script for the film from Warner Bros. Pictures. In 2026, Kane Parsons also expressed interest in directing a Portal film.
In the second half of 1945, Thomas began reading for the BBC Radio programme, Book of Verse, broadcast weekly to the Far East. This provided Thomas with a regular income and brought him into contact with Louis MacNeice, a congenial drinking companion whose advice Thomas cherished. On 29 September 1946, the BBC began transmitting the Third Programme, a high-culture network which provided opportunities for Thomas. He appeared in the play Comus for the Third Programme, the day after the network launched, and his rich, sonorous voice led to character parts, including the lead in Aeschylus's Agamemnon and Satan in an adaptation of Paradise Lost. Thomas remained a popular guest on radio talk shows for the BBC, who regarded him as "useful should a younger generation poet be needed". He had an uneasy relationship with BBC management and a staff job was never an option, with drinking cited as the problem. Despite this, Thomas became a familiar radio voice and within Britain was "in every sense a celebrity". The publication of Deaths and Entrances in February 1946 was a major turning point for Thomas. Poet and critic Walter J. Turner commented in The Spectator, "This book alone, in my opinion, ranks him as a major poet".
The death of Yazid in 683 led to a major leadership crisis in the caliphate, and "the power of his house seemed to collapse everywhere", in the words of Orientalist Julius Wellhausen. Ubayd Allah initially neglected to support Yazid's son and designated successor, Mu'awiya II and secured oaths of allegiance to himself from the Basran Arab nobility. In a speech addressed to them, he emphasized his connection to Basra and promised to maintain the wealth of the city's inhabitants. Nonetheless, the Basrans turned against him, forcing him to abandon his palace. He was replaced by Abd Allah ibn al-Harith, a member of the Banu Hashim. Ubayd Allah took refuge with the Azdi chieftain Mas'ud ibn Amr in late 683 or early 684. He plotted to restore his governorship by encouraging Mas'ud to form an alliance of the Yamani and Rabi'a tribes against his opponents from the Banu Tamim and Ibn al-Harith. Mas'ud took to the pulpit of Basra's mosque to stir up the revolt, but Tamimi tribesmen under Ibn al-Harith and their asawira allies under Mah-Afridhun, stormed the building and killed Mas'ud. After Mas'ud's death, Ubayd Allah fled the city practically alone in March 684, taking the Syrian desert route to Hawran or Palmyra. In his rush to escape, he left his wife and family behind. When Ubayd Allah arrived in Syria, he found it in political disarray; Caliph Mu'awiya II had died weeks into his rule and a power vacuum ensued with many Syrian noblemen, particularly from the Qaysi tribes, switching allegiance to the rival, Mecca-based caliphate of Abd Allah ibn al-Zubayr.
As nitrous oxide in its extensive operation appears capable of destroying physical pain, it may probably be used with advantage during surgical operations in which no great effusion of blood takes place.
Sources: en.wikipedia.org
Texts on Wikisource: Beck, Archibald Frank (1911). "Waterloo Campaign, 1815". Encyclopædia Britannica. Vol. 28 (11th ed.). pp. 371–381. Maude, Frederic Natusch (1911). "Napoleonic Campaigns". Encyclopædia Britannica. Vol. 19 (11th ed.). pp. 212–236. Robinson, Charles Walker (1911). "Peninsular War". Encyclopædia Britannica. Vol. 21 (11th ed.). pp. 90–98. Rose, John Holland (1911). "Napoleon I.". Encyclopædia Britannica. Vol. 19 (11th ed.). pp. 190–211. "A new scholarly journal in 2023: European Review of Studies on the Napoleonic and Restoration Periods" The Legend of Bonaparte The Napoleonic Wars Exhibition held by The European Library 15th Kings Light Dragoons (Hussars) Re-enactment Regiment 2nd Bt. 95th Rifles Reenactment and Living History Society The Napoleonic Wars Collection Website Napoleon, His Army and Enemies Napoleonic Guide War and Peace by Leo Tolstoy at Project Gutenberg Napoleonic Wars Fondation Napoléon The Napoleon Series
=== Inequalities === People living with AD and other forms of dementia and their unpaid carers might face inequalities in access to and the quality of care and support services. These inequalities can depend on various factors, including socio-economic background, housing situation, education level, gender, and race. People might have differences in how easily they can access AD services based on where they live. On a global level, people in low-and middle-income countries have fewer available facilities and services, and have greater difficulties accessing these than people living in high-income countries. As a result of AD and other forms of dementia being less recognised and treated in the healthcare systems of these countries, the level of awareness of AD as something caused by disease is relatively lower. At the same time, the local socio-cultural understandings of aging, senility, and eldercare may have larger effects on care provision and the reception of medical services. On a national level, people with AD might have unequal access to care based on where they live. This can manifest on a regional level, with people in rural areas facing more difficulties than those in urban areas. Inequalities can also affect smaller local units as well, for example people living in the same city might receive different or less frequent care based on their postcodes or the street they live in. Inequalities also affect people with AD from ethnic minority groups.
However, creatine kinase-MB isoform and myoglobin levels circulating in the blood are increased after exercising. Excessive cooling may impede the recovery process by keeping the Creatine kinase-MB isoform and myoglobin levels increased 2–3 days post exercise. When possible, the affected limb is elevated above the level of the heart, and is compressed using adhesive tape. Evidence supporting elevation and compression is weak, but continues to be widely practiced.
=== Cardiac involvement === About 30% of MCTD patients have symptomatic heart disease, whereas up to 40% have subclinical cardiac illness. The most common ECG abnormalities are hemiblock, bundle branch block, and atrioventricular block. Pericarditis is the most common clinical indication of cardiac involvement, affecting up to 40% of patients.
Anandamide, derived from arachidonic acid, is a partial agonist at CB1 and CB2 receptors, with potency similar to THC at CB1. Found in nearly all tissues and plants like chocolate, it also acts on vanilloid receptors.
Sources: en.wikipedia.org
However, even the smallest proteins have over 1000 atoms, which makes determining their structure far more complex. In 1934, Dorothy Crowfoot Hodgkin had taken crystallographic data on the structure of the small protein, insulin, although the structure of that and other proteins were not solved until the late 1960s. However, pioneering X-ray fiber diffraction data had been collected in the early 1930s for many natural fibrous proteins such as wool and hair by William Astbury, who suggested that "globular proteins in general might be folded from elements essentially like the elements of fibrous proteins." Since protein structure was so poorly understood in the 1930s, the physical interactions responsible for stabilizing that structure were likewise unknown. Astbury hypothesized that the structure of fibrous proteins was stabilized by hydrogen bonds in β-sheets. The idea that globular proteins are also stabilized by hydrogen bonds was proposed by Dorothy Jordan Lloyd in 1932, and championed later by Alfred Mirsky and Linus Pauling. At a 1933 lecture by Astbury to the Oxford Junior Scientific Society, physicist Charles Frank suggested that the fibrous protein α-keratin might be stabilized by an alternative mechanism, namely, covalent crosslinking of the peptide bonds by the cyclol reaction above. The cyclol crosslink draws the two peptide groups close together; the N and C atoms are separated by ~1.5 Å, whereas they are separated by ~3 Å in a typical hydrogen bond. The idea intrigued J. D.
==== Malaria ==== The President's Malaria Initiative, started with help from George W. Bush, has contributed to a more than 60% reduction in malaria deaths, saved 7.6 million lives, and prevented 1.5 billion malaria cases globally between 2000 and 2019. PMI has supported malaria prevention and control for over 500 million at-risk people in Africa. However, the USAID funding of PMI has been cut an estimated 47% as of June 2025. In countries such as the Democratic Republic of the Congo (DRC), these funds had supported the supply of antimalarial drugs to numerous health zones, including preventive treatments for pregnant women. Health officials in the DRC reported that the effects of these cuts were already being felt, with increased risk of severe illness and death from malaria among vulnerable populations. Former aid workers and experts also expressed concern that reduced funding undermined disease surveillance systems that help detect malaria and other outbreaks early. Such surveillance not only protects affected countries but also contributes to U.S. health security by limiting the global spread of disease. Aid organizations also highlighted how these cuts create a "vicious cycle," with malnutrition and malaria reinforcing one another. Reductions in U.S. support for nutrition programs increase children's vulnerability to malaria and other diseases, while higher malaria infections can worsen malnutrition.
Enzymatic reporters (e.g., LacZ) encode enzymes that catalyze reactions yielding a visible product. For example, β-galactosidase (encoded by LacZ) cleaves X-gal to produce a blue color, allowing easy identification of successful gene disruption (white colonies) versus intact genes (blue colonies). Bioluminescent reporters (e.g., luciferase) produce light via chemical reactions, enabling live-cell imaging and promoter studies without external light sources. Colorimetric reporters (e.g., CAT) generate detectable color changes when enzymes react with substrates, measurable via spectrophotometry or TLC. Selectable markers (e.g., Neo) confer antibiotic resistance (e.g., to G418), ensuring only transformed cells survive in selective media. In the case of selectable-marker reporters such as CAT, the transfected population can be grown on a chloramphenicol-containing substrate. Only cells with the CAT gene survive, confirming successful transformation.
=== As biophysical models === Synthetic condensates enable complex investigation of the property of biological condensates in vivo. Using synthetic condensates, researchers showed its strong capability to buffer intracellular concentration or reduce noise. Under non-equilibirum environment of fast-growing bacteria, a synthetic organelle like RNA-based TEARS can in fact reversely amplify the noise by asymmetric division. In the same article, TEARS have been used to recruit multiple components like split GFP and present tunable composition control of biological condensates.
Sources: en.wikipedia.org
Lyophilized means the material was frozen and then dried under vacuum, leaving a solid powder or cake. The process removes most of the water or solvent. The resulting peptide is typically more stable for storage than a solution.
Hydrophobic peptides may not disperse well in water alone because water cannot effectively solvate nonpolar regions. A small amount of a miscible organic solvent can improve wetting and dissolution. The choice depends on the peptide and the analytical method.
A clear solution indicates that visible particles are absent, but it does not confirm peptide identity, purity, or exact concentration. Those properties require analytical methods such as mass spectrometry and chromatography. Concentration is often estimated from the weighed mass or measured by a validated assay.
Lyophilization removes water to produce a dry peptide preparation. Reconstitution adds a solvent back to that preparation to create a liquid solution. The two processes are complementary steps in the lifecycle of many peptide products.